Prolactin Levels After Switching to Paliperidone Palmitate in Patients with Schizophrenia.

Masaru Nakamura, Takahiko Nagamine, Goro Sato, Kazue Besho

Open access · greenAbstract read

In one paragraph

Article in Innovations in clinical neuroscience. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it

0cells of the map it votes in

3citing papers in PubMed

1.4field-weighted citation impact, top 18% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 13 citations in OpenAlex.

Safety Outcomes with the Long-Acting Subcutaneous Antipsychotic TV-46000 in Schizophrenia: A Post Hoc Analysis of Behavioral, Neuromotor, Endocrine, and Cardiometabolic Outcomes from Two Phase 3 Studies.CNS drugs · 2025
Trial
Immunoendocrine Peripheral Effects Induced by Atypical Antipsychotics.Frontiers in endocrinology · 2020
Review
PROLACTIN LEVELS IN PATIENTS WITH SCHIZOPHRENIA WHO WERE SWITCHED FROM DAILY TO ONCE-MONTHLY ARIPIPRAZOLE TREATMENT.Innovations in clinical neuroscience · 2018
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Masaru NakamuraDr. Nakamura is with the Department of Psychiatric Internal Medicine, Kosekai-Kusatsu Hospital, Hiroshima, Japan; Dr. Nagamine is with the Department of Psychiatric Internal Medicine, Shinseikai-Ishii Memorial Hospital, Iwakuni, Japan; Dr. Sato is with the Department of Psychiatry, Kosekai-Kusatsu Hospital, Hiroshima, Japan; and PhC. Besho is with the Department of Pharmacy, Kosekai-Kusatsu Hospital, Hiroshima, Japan.

Takahiko NagamineDr. Nakamura is with the Department of Psychiatric Internal Medicine, Kosekai-Kusatsu Hospital, Hiroshima, Japan; Dr. Nagamine is with the Department of Psychiatric Internal Medicine, Shinseikai-Ishii Memorial Hospital, Iwakuni, Japan; Dr. Sato is with the Department of Psychiatry, Kosekai-Kusatsu Hospital, Hiroshima, Japan; and PhC. Besho is with the Department of Pharmacy, Kosekai-Kusatsu Hospital, Hiroshima, Japan.

Goro SatoDr. Nakamura is with the Department of Psychiatric Internal Medicine, Kosekai-Kusatsu Hospital, Hiroshima, Japan; Dr. Nagamine is with the Department of Psychiatric Internal Medicine, Shinseikai-Ishii Memorial Hospital, Iwakuni, Japan; Dr. Sato is with the Department of Psychiatry, Kosekai-Kusatsu Hospital, Hiroshima, Japan; and PhC. Besho is with the Department of Pharmacy, Kosekai-Kusatsu Hospital, Hiroshima, Japan.

Kazue BeshoDr. Nakamura is with the Department of Psychiatric Internal Medicine, Kosekai-Kusatsu Hospital, Hiroshima, Japan; Dr. Nagamine is with the Department of Psychiatric Internal Medicine, Shinseikai-Ishii Memorial Hospital, Iwakuni, Japan; Dr. Sato is with the Department of Psychiatry, Kosekai-Kusatsu Hospital, Hiroshima, Japan; and PhC. Besho is with the Department of Pharmacy, Kosekai-Kusatsu Hospital, Hiroshima, Japan.

nLIGHT (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

paliperidone-ERPaliperidone palmitateprolactinrisperidone long-acting injectableswitching

Identifiers

PMID27800283

PMCPMC5077256

OpenAlexW2546857509

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.